SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) — Recursion RXRX, a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its…Read More
Recursion to Participate in Upcoming Investor Conferences Recursion Pharmaceuticals NASDAQRXRX
